Laman UtamaPHIO • NASDAQ
add
Phio Pharmaceuticals Corp
$2.70
Selepas Waktu Dagangan:(0.00%)0.00
$2.70
Tutup: 16 Apr, 4:05:31 PTG GMT-4 · USD · NASDAQ · Penafian
Tutup sebelumnya
$2.43
Julat hari
$2.35 - $2.94
Julat tahun
$0.97 - $9.79
Permodalan pasaran
12.90J USD
Bilangan Purata
5.65J
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
NASDAQ
Berita pasaran
Stock Titan
6 jam lalu
X3 Holdings Dodges Delisting Risk: Successfully Maintains Crucial Nasdaq Status
14.67%
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Dis 2024info | Perubahan T/T |
|---|---|---|
Hasil | — | — |
Perbelanjaan pengendalian | 689.00K | -10.05% |
Pendapatan bersih | -1.63J | 14.20% |
Margin untung bersih | — | — |
Pendapatan bagi setiap syer | — | — |
EBITDA | -1.67J | 5.05% |
Kadar cukai berkesan | — | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Dis 2024info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 5.38J | -36.61% |
Jumlah aset | 5.74J | -38.72% |
Jumlah liabiliti | 1.02J | -37.88% |
Jumlah ekuiti | 4.72J | — |
Syer tertunggak | 4.78J | — |
Harga kepada buku | 0.89 | — |
Pulangan pada aset | -72.14% | — |
Pulangan pada modal | -86.57% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Dis 2024info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | -1.63J | 14.20% |
Tunai daripada operasi | -1.37J | 42.15% |
Tunai daripada pelaburan | 8.00K | — |
Tunai daripada pembiayaan | 1.36J | -43.61% |
Perubahan bersih dalam tunai | -8.00K | -124.24% |
Aliran tunai bebas | -783.25K | 51.92% |
Perihal
Phio Pharmaceuticals Corporation is a US clinical stage biotechnology company developing its INTASYL siRNA in immuno-oncology. Formerly known as RXi Pharmaceuticals, the company's name was changed to Phio Pharmaceuticals in 2018. Wikipedia
Diasaskan
2011
Ibu pejabat
Tapak web
Pekerja
5
